Aim To evaluate the immunogenicity and safety of a reduced antigen diphtheria-tetanus-
acellular pertussis-inactivated poliovirus (dTap-IPV B) vaccine (Boostrix-IPV, GSK) as a pre …

This open, randomised controlled trial studied the immunogenicity and reactogenicity of two
combined low-dose diphtheria, tetanus and acellular pertussis vaccines (Td5aP-IPV …

This serological follow up study assessed the kinetics of antibody response in children who
previously participated in a single centre, open-label, randomised controlled trial of low …

An antenatal pertussis vaccination programme was introduced in 2012 in the UK in the
context of a national outbreak of pertussis. It has been shown that a lower antibody response …

High rates of pertussis disease in adolescents suggest that additional boosting against
pertussis would be beneficial. A combined acellular-pertussis-containing booster vaccine …

Background: The rising incidence of pertussis amongst adults and adolescents in
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …

Background: Pertussis occurs in older children, adolescents and adults due to waning
immunity after primary vaccination. Booster vaccination for pre-school children has been …

Reduced-antigen-content pertussis vaccines designed initially for booster vaccination of
adolescents and adults can also be used to vaccinate pre-school age children. Combination …

This study evaluated the safety and immunogenicity of combined diphtheria, tetanus,
acellular pertussis, inactivated poliomyelitis vaccine (DTPa-IPV) given as primary …

In this trial we studied the immunogenicity and reactogenicity of three different ACVAs and
the RIVM-WCV combined with DT-IPV, administered as a booster in children four years of …